European research trends in nuclear medicine

Written by associate editors of the Annals of Nuclear Medicine, this invited review article is intended to offer our readers a condensed global view on the high-quality research work that has been published in Europe last year. We have divided this article into five sections. The first three sections from the oncology category include “[(18)F]fluorodeoxyglucose (FDG) positron-emission tomography (PET) for therapy monitoring in malignant lymphoma”, “[(18)F]fluoromisonidazole (FMISO) PET for hypoxia”, and “lymphoscintigraphy update”. It is followed by a section on “amyloid PET for Alzheimer’s disease” using [(11)C]Pittsburgh Compound B (PiB) and [(18)F]florbetapir from the neurology category. The final section reviews three original articles in the field of “basic and translational molecular imaging” regardless of the category, which investigated new PET tracers such as L-4-borono-2-[(18)F]fluoro-phenylalanine (FBPA), O-(2-[(18)F]fluoroethyl)-L-tyrosine (FET) and (64)Cu-NOTA-pertuzumab in small animals. We hope that this review article will arouse greater interest in our readers in recent European research trends in the field of nuclear medicine.